510(k) · Cleared
Recalled · Class II · 2013Duragen XS Dural Regeneration Matrix
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Integra Lifesciences Corp. · GXQ Dura Substitute
Cleared on Aug 23, 2007 as substantially equivalent to K032693 (Integra Lifesciences Corp., 2003) after a 15-day review. Its family tree reaches back 4 generations to 1995. 2 later devices descend from it. It has been recalled 6 times.
- Decided
- Aug 23, 2007
- Review
- 15 days
- Class
- Class II
- Product code
- GXQ
- Recalls
- 6
- Predicates
- 1
Its longest line of descent runs back 4 generations to K950956 (1995). 7 ancestors in all, the oldest K910555 (1992). 2 later devices descend from it, 1 citing it directly.
- Root · 4 generations backK950956 Dura-Guard Dural Repair Patch, Dura-Guard Dura SubstituteBio-Vascular, Inc. · 1995
- 3 generations backK973706 Dura-Guard-Dural Repair PatchBio-Vascular, Inc. · 1997
- 2 generations backK982180 Duragen Dural Graft MatrixIntegra Lifesciences Corp. · 1999 · Recalled
- 1 generation backK032693 Duragen Plus Dural Graft MatrixIntegra Lifesciences Corp. · 2003 · Recalled
- This deviceK072207 Duragen XS Dural Regeneration MatrixIntegra Lifesciences Corp. · 2007
- Descendant · cites it directly · 1 of its ownK120600 Duragen Secure Dural Regneration MatrixIntegra Life Sciences · 2012
- Descendant · 2 generations on · 0 of its ownK163456 DuraGen Secure Dural Regeneration MatrixIntegra LifeSciences Corporation · 2017
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K950956 | Dura-Guard Dural Repair Patch, Dura-Guard Dura Substitute | Bio-Vascular, Inc. | 1995 | — |
| −3 | K973706 | Dura-Guard-Dural Repair Patch | Bio-Vascular, Inc. | 1997 | — |
| −2 | K982180 | Duragen Dural Graft Matrix | Integra Lifesciences Corp. | 1999 | 1 |
| −1 | K032693 | Duragen Plus Dural Graft Matrix | Integra Lifesciences Corp. | 2003 | 1 |
| 0 (this device) | K072207 | Duragen XS Dural Regeneration Matrix | Integra Lifesciences Corp. | 2007 | — |
| +1 | K120600 | Duragen Secure Dural Regneration Matrix | Integra Life Sciences | 2012 | — |
| +2 | K163456 | DuraGen Secure Dural Regeneration Matrix | Integra LifeSciences Corporation | 2017 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1992 | 1 | 0 |
| 1995 | 1 | 0 |
| 1997 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2012 | 1 | 0 |
| 2017 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GXQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GXQ device
- #1 K251191 Collagen Dura Regeneration Membrane - Repairscore 12.2 · 7 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K032693 | Duragen Plus Dural Graft MatrixSummary page 1…e: The DuraGen XSTm Dural Regeneration Matrix is substantially equivalent in function and intended use to the currently marketed DuraGen Plus® Dural Regeneration Matrix (K032693). Intended Use: DuraGen XSTm Dural Regeneration Matrix is indicated as a dura substitute for the repair of dura mater. Device D… | 2003 |
What descends from it? (2)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K120600 | Duragen Secure Dural Regneration Matrix | 2012 | 1 |
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Mar 28, 2013 | Class II | Z-1285-2013 | Process control | Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products. |
| Mar 28, 2013 | Class II | Z-1286-2013 | Process control | Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products. |
| Sep 29, 2010 | Not classified | Z-0450-2011 | Other | Test results no longer support a 3 year shelf life. |
| Sep 29, 2010 | Not classified | Z-0451-2011 | Other | Test results no longer support a 3 year shelf life. |
| Sep 29, 2010 | Not classified | Z-0452-2011 | Other | Test results no longer support a 3 year shelf life. |
| Sep 29, 2010 | Not classified | Z-0453-2011 | Other | Test results no longer support a 3 year shelf life. |
The 5 latest of 6 recalls; the web page lists all.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 12 years and passes through 2 companies; a new generation was cleared every 3.9 years on median.
- 2 of the 7 ancestors have a recall of any class.
- Of its descendants, K120600 (Integra Life Sciences, 2012) has gone furthest, with 1 descendant of its own.
- 3 other devices also cite its predicate K032693.
How does its category compare?
All GXQ devicesGXQ Dura Substitute: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · GXQ
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GXQ
94in 2016
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GXQ
2in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GXQ
61in 2025
MAUDE reports naming product code GXQ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 55 |
| 2008 | 0 | — | 0 | 43 |
| 2009 | 0 | — | 0 | 46 |
| 2010 | 1 | — | 6 | 36 |
| 2011 | 0 | — | 0 | 31 |
| 2012 | 2 | — | 0 | 38 |
| 2013 | 3 | 181 | 1 | 72 |
| 2014 | 1 | — | 0 | 18 |
| 2015 | 3 | 214 | 0 | 62 |
| 2016 | 3 | 94 | 0 | 58 |
| 2017 | 2 | — | 0 | 57 |
| 2018 | 0 | — | 0 | 94 |
| 2019 | 1 | — | 0 | 63 |
| 2020 | 0 | — | 0 | 114 |
| 2021 | 0 | — | 2 | 76 |
| 2022 | 1 | — | 0 | 59 |
| 2023 | 1 | — | 0 | 109 |
| 2024 | 0 | — | 2 | 55 |
| 2025 | 2 | — | 0 | 61 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
DuraGen XSTM Dural Regeneration Matrix is indicated as a dura substitute for the repair of dura mater.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K072207 · printed Nov 4, 2026
Cite this page
510(k) Report. “K072207: Duragen XS Dural Regeneration Matrix.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K072207
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026